Savient Pharmaceuticals, Inc. (SVNT) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	28.44M
Short-term investments	6.18M
Accounts receivable, net	6.82M
Inventories, net	1.26M
Prepaid expenses and other current assets	4.68M
Total current assets	47.38M
Deferred income taxes, net
Property and equipment, net	1.7M
Deferred financing costs, net	4.27M
Other assets (including restricted cash)
Total assets	56.14M
Accounts payable	1.62M
Deferred revenues	773K
Deferred income taxes
Accrued interest on convertible notes	2.98M
Other current liabilities	16.96M
Total current liabilities	23.96M
Convertible notes, net of discount of $56,677	100.07M
Other liabilities	2.77M
Commitments and contingencies
Preferred stock-$.01 par value 4,000,000 shares authorized; no shares issued	0
Common stock-$.01 par value 150,000,000 shares authorized; 71,349,000 issued and outstanding at June 30, 2011 and 70,259,000 shares issued and outstanding at December 31, 2010	737K
Additional paid-in-capital	400.58M
Accumulated deficit	-606.23M
Accumulated other comprehensive income	-1.41M
Total stockholders' equity	-206.32M
Total liabilities and stockholders' equity	56.14M

Entities mentioned with SVNT

View All Entities